Abstract
Gene silencing using antisense RNA or RNA interference (RNAi) is now a popular method used in eukaryotes. However, RNAi mechanism is absent in bacteria, and hence, single-stranded antisense RNAs, DNAs or nucleic acid analogs are used. Gene silencing in bacteria are achieved by either one of the following two approaches: expressing antisense RNAs using expression plasmids or adding synthetic antisense agents into the culture media. Recently, many advances on this method have been reported. In particular, the problem of low silencing efficiency has been solved remarkably, and as a result, this method is being used practically in biotechnology. This review mainly deals with the features and applications of gene silencing as a gene function subtracting method. Also, gene disruption is described as a competing and mutually complementary method.
Keywords: Antisense RNA, Escherichia coli, gene disruption, gene knock-down, gene knock-out, gene silencing, growth essential gene, LNA, locked nucleic acid, paired-termini, peptide nucleic acid, PNA, RNA silencing, ribosome-binding site.
Current Biotechnology
Title:Subtracting Gene Function by Gene Silencing and Disruption in Bacteria
Volume: 1 Issue: 2
Author(s): Nobutaka Nakashima, Shan Goh and Tomohiro Tamura
Affiliation:
Keywords: Antisense RNA, Escherichia coli, gene disruption, gene knock-down, gene knock-out, gene silencing, growth essential gene, LNA, locked nucleic acid, paired-termini, peptide nucleic acid, PNA, RNA silencing, ribosome-binding site.
Abstract: Gene silencing using antisense RNA or RNA interference (RNAi) is now a popular method used in eukaryotes. However, RNAi mechanism is absent in bacteria, and hence, single-stranded antisense RNAs, DNAs or nucleic acid analogs are used. Gene silencing in bacteria are achieved by either one of the following two approaches: expressing antisense RNAs using expression plasmids or adding synthetic antisense agents into the culture media. Recently, many advances on this method have been reported. In particular, the problem of low silencing efficiency has been solved remarkably, and as a result, this method is being used practically in biotechnology. This review mainly deals with the features and applications of gene silencing as a gene function subtracting method. Also, gene disruption is described as a competing and mutually complementary method.
Export Options
About this article
Cite this article as:
Nakashima Nobutaka, Goh Shan and Tamura Tomohiro, Subtracting Gene Function by Gene Silencing and Disruption in Bacteria, Current Biotechnology 2012; 1 (2) . https://dx.doi.org/10.2174/2211550111201020166
DOI https://dx.doi.org/10.2174/2211550111201020166 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Insights for Multifactorial Disease Therapy: The Challenge of the Symbiotic Drugs
Current Drug Therapy Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Microwave-assisted Synthesis of Novel Triazolyl Pyrazolyl Pyrazoline Substituted Coumarins and Their Antimicrobial Activity
Current Microwave Chemistry Xenicane Natural Products: Biological Activity and Total Synthesis
Current Pharmaceutical Design Whole Cell Biocatalysts for the Preparation of Nucleosides and their Derivatives
Current Pharmaceutical Design New Insights in Design and Development of Antitubercular Drugs
Current Bioactive Compounds 4-Mer Hyaluronan Oligosaccharides Stimulate Inflammation Response in Synovial Fibroblasts in Part via TAK-1 and in Part via p38-MAPK
Current Medicinal Chemistry Predicting Protein-Ligand Binding Sites Based on an Improved Geometric Algorithm
Protein & Peptide Letters Cytokines as a Therapeutic Target for Allergic Diseases: A Complex Picture
Current Pharmaceutical Design Childhood Hospitalisations for Physical Disease and Risk of Mental Disorders During Adolescence and Early Adulthood
Adolescent Psychiatry Cytokine Therapies in Crohns Disease: Where are We Now and where should We Go?
Inflammation & Allergy - Drug Targets (Discontinued) Anomalous Vascular Supply of Bronchial Circulation in Cystic Fibrosis Patients with Massive Hemoptysis
Current Respiratory Medicine Reviews Antimicrobial Effects of Chemical Compounds Isolated from Traditional Chinese Herbal Medicine (TCHM) Against Drug-Resistant Bacteria: A Review Paper
Mini-Reviews in Medicinal Chemistry Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade
Recent Patents on Anti-Cancer Drug Discovery Role of Cytokines in Chlamydia trachomatis Protective Immunity and Immunopathology
Current Pharmaceutical Design Predicting the Potential Public Health Impact of Disease-Modifying HIV Vaccines in South Africa: The Problem of Subtypes
Current Drug Targets - Infectious Disorders Induction of Oral Tolerance with Transgenic Plants Expressing Antigens for Prevention/Treatment of Autoimmune, Allergic and Inflammatory Diseases
Current Pharmaceutical Biotechnology In silico Analysis of Several Signal Peptides for the Excretory Production of Reteplase in Escherichia coli
Current Proteomics Recent Advances Using Supercritical Fluid Techniques for Pulmonary Administration of Macromolecules via Dry Powder Formulations
Drug Delivery Letters Insights in Nanoparticle-Bacterium Interactions: New Frontiers to Bypass Bacterial Resistance to Antibiotics
Current Pharmaceutical Design